The HOPE Asia network 2022 up-date consensus statement on morning hypertension management
Journal
Journal of clinical hypertension (Greenwich, Conn.)
Journal Volume
24
Journal Issue
9
Pages
1112
Date Issued
2022-09
Author(s)
Kario, Kazuomi
Wang, Ji-Guang
Chia, Yook-Chin
Li, Yan
Siddique, Saulat
Shin, Jinho
Turana, Yuda
Buranakitjaroen, Peera
Chen, Chen-Huan
Cheng, Hao-Min
Van Huynh, Minh
Nailes, Jennifer
Sukonthasarn, Apichard
Zhang, Yuqing
Sison, Jorge
Soenarta, Arieska Ann
Park, Sungha
Sogunuru, Guru Prasad
Tay, Jam Chin
Teo, Boon Wee
Tsoi, Kelvin
Verma, Narsingh
Hoshide, Satoshi
Abstract
Morning hypertension is an important clinical target in the management of hypertension for perfect 24-h blood pressure (BP) control. Morning hypertension is generally categorized into two types: "morning surge" type and "sustained nocturnal and morning hypertension" type. The "morning surge" type is characterized by an exaggerated morning blood pressure surge (MBPS), and the "sustained nocturnal and morning hypertension" type with continuous hypertension from nighttime to morning (non-dipper/riser type). They can be detected by home and ambulatory blood pressure measurements (HBPM and ABPM). These two forms of morning hypertension both increase the risk of cardiovascular and renal diseases, but may occur via different pathogenic mechanisms and are associated with different conditions. Morning hypertension should be treated to achieve a morning BP level of < 135/85 mmHg, regardless of the office BP. The second target morning BP levels is < 125/75 mmHg for high-risk patients with morning hypertension and concomitant diseases. Morning hypertension is more frequently found in Asians, than in Westerners. Thus, the management of morning hypertension is especially important in Asia. The detection of morning hypertension and the individual home BP-guided treatment approach targeting morning BP in combination with ABPM, and the optimal treatment of morning hypertension would reduce cardiovascular events in Asia.
Subjects
Asia; antihypertensive medication; bedtime dosing; hypertension; morning; personalized approach
SDGs
Publisher
WILEY
Type
journal article